No Data
No Data
Express News | HC Wainwright & Co. Reiterates Neutral on HilleVax, Maintains $2 Price Target
HilleVax Analyst Ratings
Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks
HilleVax | 10-K: FY2024 Annual Report
Express News | Hillevax Inc: Exploring Potential for Continued Development of Its Norovirus Vaccine Candidates in Adults
Express News | HilleVax Q4 EPS $(0.68) Misses $(0.33) Estimate